Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients

Pathobiology

Volumn 67, Issue 3, 1999, Pages 123-128

  Kim, Chul Woo ^a   Choi, Sang Hoon ^b   Chung, Eun Joo ^a   Lee, Min Jung ^a   Byun, Eun Kyung ^a   Ryu, Min Hee ^a   Bang, Yung Jue ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Kunsan National University   (South Korea)

Author keywords

CD8+28 T cells; Immune suppression; Protein tyrosine kinase; Stomach cancer

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; PROTEIN TYROSINE KINASE;

ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD28; ANTIGENS, CD3; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); LYMPHOCYTES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; T-LYMPHOCYTES;

EID: 0033011213     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028061     Document Type: Article

References (26)

1. Olive RT, Nouri AM: T-cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy. Cancer Surv 1992;13:173-204.
2. Mizoguchi H, O'Shea J, Longo D, Loeffler C, McVicar D, Ochoa A: Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992;258:1795-1798.
3. lck in T cell infiltrating human renal-cell carcinoma. Cancer Res 1993; 53:5613-5616.
4. Nakagomi H, Peterson M, Magnusson I, Juhlin C, Matuda M, Mellstedt H, Taupin J-L, Vivier E, Anderson P, Kiessling R: Decreased expression of the signal-transducing ζ chain in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res 1993;53: 5610-5612.
5. Salvador S, Gansbacher B, Pizziment A, Zier K: Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2 secreting tumors. J Immunol 1994;153:5176-5180.
6. Aoe T, Okamoto Y, Saito T: Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med 1995; 181:1881-1886.
7. Tartour E, Latour S, Mathiot C, Thiounn N, Mosseri V, Joyeux I, d'Enghien CD, Lee R, Debré B, Fridman WH: Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 1995;63:205-212.
8. Zea AH, Curti BD, Longo DL, Alvord WG, Strobl SL, Mizoguchi H, Creekmore SF, O'Shea JL, Powers GC, Kuba WJ, Ochoa AC: Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1996;1:1327-1335.
9. Lai P, Rabinowich H, Crowley-Nuwick PA, Bell MC, Mantusani G, Whiteside TL: Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 1996;2:161-173.
10. Choi SH, Chung EJ, Whang DY, Lee SS, Jang Y-S, Kim CW: Alteration of signal-transducing molecules in tumor-infiltrating lymphocytes and peripheral blood T lymphocytes from human colorectal carcinoma patients. Cancer Immunol Immunother 1998;45:299-305.
11. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994;15:321-331.
12. lck association with CD4 is required for the interaction between CD4 and the TCR/CD3 complex and for optimal antigen stimulation. J Immunol 1992;148: 2159-2166.
13. Strauss D, Weiss A: Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992;70:585-592.
14. fyn ZAP-70, and CD3ζ despite suppressed cytolytic activity. J Exp Med 1995;182: 1029-1036.
15. Wang Q, Stanley J, Kudoh S, Myles J, Kolenko V, Yi T, Tubbs R, Bukowski R, Finke J: T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J Immunol 1995;155:1382-1392.
16. Whiteside TL, Parmiani G: Tumor-infiltrating lymphocytes: Their phenotype, functions and clinical use. Cancer Immunol Immunother 1994;39:15-21.
17. Goedegebuure PS, Eberlein TJ: The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors. Immunol Res 1995;14:119-126.
18. Lee KY, Goedegebuure PS, Linehan DC, Eberlein TJ: Immunoregulatory effects of CD4+ T helper subsets in human melanoma. Surgery 1995;117:365-372.
19. Baxevanis CN, Dedoussis GVZ, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M: Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Cancer 1994; 74:1275-1284.
20. Freedman RS, Ioannides CG, Mathioudakis G, Platsoucas CD: Novel immunologic strategies in ovarian carcinoma. Am J Obstet Gynecol 1994;167:1470-1478.
21. Azuma M, Phillips J, Lanier L: CD28 T lymphocytes. J Immunol 1993;150:1147-1152.
22. Lombard G, Sidhu S, Batchelor R, Lechler T: Anergic T cells as suppressor cells in vitro. Nature 1994;264:1587-1590.
23. Dutra WO, Martins-Filho OA, Pinto-Dias JC, Brener Z, Gazzinelli G, Carvalho JF, Colley DG: Chagasic patients lack CD28 expression in many of their circulating T lymphocytes. Scand J Immunol 1996;43:88-93.
24. Roos MT, Miedema F, Meinesz AP, De Leeuw NA, Pakker NG, Lange JM, Coutinho RA, Schellekens PT: Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: Correlation with decreased CD28 expression. Clin Exp Immunol 1996;10:409-415.
25. Daniel PT, Kroidl A, Cayeux S, Bargou B, Blankenstein T, Dorken B: Costimlatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis. J Immunol 1997;159: 3808-3815.
26. Walker LSK, Mcleod JD, Boulougouris G, Patel YI, Hall ND, Sansom DM: Down-regulation of CD28 via Fas (CD95): influence of CD28 on T-cell apoptosis. Immunology 1998; 94:41-47.